D. E. Shaw & Co., Inc. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2022$3,372,000
+120.8%
678,504
+65.2%
0.00%
+100.0%
Q2 2022$1,527,000
+186.0%
410,677
+331.1%
0.00%
Q1 2022$534,000
-73.4%
95,268
-71.2%
0.00%
-100.0%
Q4 2021$2,009,000
-45.4%
330,501
-12.4%
0.00%
-33.3%
Q3 2021$3,677,000
+205.1%
377,470
+347.4%
0.00%
+200.0%
Q2 2021$1,205,00084,3720.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders